Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The associations of adipokines with selected markers of the renin–angiotensinogen–aldosterone system: the multi-ethnic study of atherosclerosis

Journal of Human Hypertension volume 29, pages 127–133 (2015)Cite this article

Subjects

Abstract

Among obese individuals, increased sympathetic nervous system (SNS) activity results in increased renin and aldosterone production, as well as renal tubular sodium reabsorption. This study determined the associations between adipokines and selected measures of the renin–angiotensinogen–aldosterone system (RAAS). The sample consisted of 1970 men and women from the Multi-Ethnic Study of Atherosclerosis who were free of clinical cardiovascular disease at baseline and had blood assayed for adiponectin, leptin, plasma renin activity (PRA) and aldosterone. The mean age was 64.7 years and 50% were female. The mean (s.d.) PRA and aldosterone were 1.45 (0.56) ng ml−1 and 150.1 (130.5) pg ml−1, respectively. After multivariable adjustment, a 1-s.d. increment of leptin was associated with a 0.55 ng ml−1 higher PRA and 8.4 pg ml−1 higher aldosterone (P<0.01 for both). Although adiponectin was not significantly associated with PRA levels, the same increment in this adipokine was associated with lower aldosterone levels (−5.5 pg ml−1, P=0.01). Notably, the associations between aldosterone and both leptin and adiponectin were not materially changed with additional adjustment for PRA. Exclusion of those taking antihypertensive medications modestly attenuated the associations. The associations between leptin and both PRA and aldosterone were not different by gender but were significantly stronger among non-Hispanic Whites and Chinese Americans than African and Hispanic Americans (P<0.01). The findings suggest that both adiponectin and leptin may be relevant to blood pressure regulation via the RAAS, in that the associations appear to be robust to antihypertension medication use and that the associations are likely different by ethnicity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Ahima RS . Central actions of adipocyte hormones. Trends Endocrinol Metab 2005; 16: 307–313.

    Article  CAS  Google Scholar 

  2. Barba G, Russo O, Siani A, Iacone R, Farinaro E, Gerardi MC et al. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11: 160–166.

    Article  Google Scholar 

  3. Jones DW, Kim JS, Andrew ME, Kim S, Hong YP . Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens 1994; 12: 1433–1437.

    Article  CAS  Google Scholar 

  4. Wofford MR, Hall JE . Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10: 3621–3637.

    Article  CAS  Google Scholar 

  5. Jones DW . Body weight and blood pressure. Effects of weight reduction on hypertension. Am J Hypertens 1996; 9: 50s–54s.

    Article  CAS  Google Scholar 

  6. Bełtowski J . Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 2006; 24: 789–801.

    Article  Google Scholar 

  7. Hausberg M, Morgan DA, Chapleau MA, Sivitz WI, Mark AL, Haynes WG . Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. J Hypertens 2002; 20: 1633–1641.

    Article  CAS  Google Scholar 

  8. Rahmouni K, Correia MLG, Haynes WG, Mark AL . Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45: 9–14.

    Article  CAS  Google Scholar 

  9. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI . Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270–278.

    Article  CAS  Google Scholar 

  10. Montani J-P, Antic V, Yang Z, Dulloo A . Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002; 26 (Suppl 2): S28–S38.

    Article  CAS  Google Scholar 

  11. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871–881.

    Article  Google Scholar 

  12. Landsberg L, Krieger DR . Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989; 2: 125S–132S.

    Article  CAS  Google Scholar 

  13. Hall JE, Louis K . Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23: 381–394.

    Article  CAS  Google Scholar 

  14. Levey AS, Stevens LA . Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 2010; 55: 622–627.

    Article  Google Scholar 

  15. Criqui MH, Kamineni A, Allison MA, Ix JH, Carr JJ, Cushman M et al. Risk factor differences for aortic versus coronary calcified atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 2289–2296.

    Article  CAS  Google Scholar 

  16. Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    CAS  Google Scholar 

  17. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 2012; 125: e2–e220.

    Article  Google Scholar 

  18. Hall JE . Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 1997; 10: 49S–55S.

    Article  CAS  Google Scholar 

  19. DiBona GF, Kopp UC . Neural control of renal function. Physiol Rev 1997; 77: 75–197.

    Article  CAS  Google Scholar 

  20. Flegal KM, Carroll MD, Kit BK, Ogden CL . Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491–497.

    Article  Google Scholar 

  21. Kelly T, Yang W, Chen C-S, Reynolds K, He J . Global burden of obesity in 2005 and projections to 2030. Int J Obes Relat Metab Disord 2008; 32: 1431–1437.

    Article  CAS  Google Scholar 

  22. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 2013; 127: e6–e245.

    PubMed  Google Scholar 

  23. He J, Klag MJ, Appel LJ, Charleston J, Whelton PK . The renin-angiotensin system and blood pressure differences between blacks and whites. Am J Hypertens 1999; 12: 555–562.

    Article  CAS  Google Scholar 

  24. Richardson SI, Freedman BI, Ellison DH, Rodriguez CJ . Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics. J Am Soc Hypertens 2013; 7: 170–179.

    Article  CAS  Google Scholar 

  25. Correia ML, de G, Haynes WG . Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 2004; 13: 215–223.

    Article  Google Scholar 

  26. Rahmouni K, Haynes WG, Morgan DA, Mark AL . Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002; 39: 486–490.

    Article  CAS  Google Scholar 

  27. Pladevall M, Williams K, Guyer H, Sadurní J, Falces C, Ribes A et al. The association between leptin and left ventricular hypertrophy: a population–based cross-sectional study. J Hypertens 2006; 24: 1447–1473.

    Article  Google Scholar 

  28. Lieb W, Sullivan LM, Aragam J, Harris TB, Roubenoff R, Benjamin EJ et al. Relation of serum leptin with cardiac mass and left atrial dimension in individuals &gt;70 years of age. Am J Cardiol 2009; 104: 602–605.

    Article  CAS  Google Scholar 

  29. Allison MA, Bluemke DA, McClelland R, Cushman M, Criqui MH, Polak JF et al. Relation of leptin to left ventricular hypertrophy (from the multi-ethnic study of atherosclerosis). Am J Cardiol 2013; 112: 726–730.

    Article  CAS  Google Scholar 

  30. Fantuzzi G . Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911–919.

    Article  CAS  Google Scholar 

  31. Flynn C, Bakris GL . Interaction between adiponectin and aldosterone. Cardiorenal Med 2011; 1: 96–101.

    Article  CAS  Google Scholar 

  32. Li P, Zhang XN, Pan CM, Sun F, Zhu DL, Song HD et al. Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes. Horm Metab Res 2011; 43: 464–469.

    Article  CAS  Google Scholar 

  33. Kotchen TA . Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010; 23: 1170–1178.

    Article  CAS  Google Scholar 

  34. Gu P, Xu A . Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord 2013; 14: 49–58.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the other investigators, the staff and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. This research was supported by grants R01-HL-088451 and R01-DK-080015, as well as contracts N01-HC-95159 through N01-HC-95169 from the National Institutes of Health.

Author information

Authors and Affiliations

  1. Department of Family and Preventive Medicine, University of California-San Diego, La Jolla, CA, USA

    M A Allison & D Rifkin

  2. Department of Pathology, University of Vermont College of Medicine, Burlington, VT, USA

    N S Jenny & M Cushman

  3. Department of Biostatistics, University of Washington, Seattle, WA, USA

    R L McClelland

  4. Department of Medicine, University of California-San Diego, La Jolla, CA, USA

    D Rifkin

Authors
  1. M A Allison
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N S Jenny
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R L McClelland
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Cushman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D Rifkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M A Allison.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allison, M., Jenny, N., McClelland, R. et al. The associations of adipokines with selected markers of the renin–angiotensinogen–aldosterone system: the multi-ethnic study of atherosclerosis. J Hum Hypertens 29, 127–133 (2015). https://doi.org/10.1038/jhh.2014.40

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2014.40

Search

Advanced search

Quick links